Procter & Gamble Health balance sheet

·Pharma & HealthChart ›
As of Jun 2024
Total assets
₹794cr−27.9% on Jun 2023
Shareholders' equity
₹538cr−28.3% on Jun 2023
Total debt
₹0.0crNo figure a year before
Cash and investments
₹239cr−45.2% on Jun 2023
₹ crore except per share
Tap a line for its trendFY25Jun 2024FY24Jun 2023FY23 and earlierAlpha Plus
Non-current assets
FY23 and earlierEvery year the company has filed comes with Alpha Plus.
126130
5.932.5
1.92.3
1.012.1
9.76.3
90.45.1
10011.4
33.725.3
1.991.9
270305
Current assets
109135
85.3116
239435
5.95.2
1.71.5
13.412.6
345570
61.391.1
515796
9.0—
7941,101
Equity
16.616.6
522734
538751
538751
Liabilities
6.99.5
6.99.5
29.636.9
0.70.0
37.246.4
167237
25.7—
193237
10.218.3
3.56.1
12.542.5
219304
256350
7941,101
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

PGHL₹5,399.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹8,962 Cr
View
In ₹ Crore except Per Share
As of
FY24
30/06/2023
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Non-current Assets
+ Property, Plant & Equipment129.6125.6——
+ Capital Work-in-Progress32.55.9——
+ Investment Property2.31.9——
+ Other Intangibles12.11.0——
+ Long-term Loans6.39.7——
+ Other Non-current Financial Assets5.190.4——
Non-current Financial Assets11.4100.2——
+ Deferred Tax Assets25.333.7——
+ Other Non-current Assets91.91.9——
Total Non-current Assets305.1270.1——
Current Assets
+ Inventories134.9109.1——
+ Trade Receivables115.785.3——
+ Cash & Cash Equivalents435.1238.5——
+ Other Bank Balances5.25.9——
+ Short-term Loans1.51.7——
+ Other Current Financial Assets12.613.4——
Current Financial Assets570.0344.8——
+ Other Current Assets91.161.3——
Total Current Assets796.1515.2——
+ Assets Held for Sale—9.0——
Total Assets1,101.2794.4——
Equity
+ Equity Share Capital16.616.6——
+ Other Equity / Reserves734.3521.6——
Equity — Owners of Parent750.9538.2——
Total Equity750.9538.2——
Liabilities
+ Other Non-current Financial Liab9.56.9——
Non-current Financial Liabilities9.56.9——
+ Provisions — Non-current36.929.6——
+ Other Non-current Liabilities0.00.7——
Non-current Liabilities46.437.2——
+ Trade Payables237.0167.0——
+ Other Current Financial Liab—25.7——
Current Financial Liabilities237.0192.7——
+ Provisions — Current18.310.2——
+ Current Tax Liabilities6.13.5——
+ Other Current Liabilities42.512.5——
Current Liabilities303.9218.9——
Total Liabilities350.3256.1——
Total Equity & Liabilities1,101.2794.4——
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.